In Alaska, where access to specialist care is challenging and emergency transfers can be harrowing, providers are using AI to ...

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

With its FDA-approved neurostimulator implant aimed at helping patients recover from stroke, MicroTransponder has raised $65 ...

The ambulance would be the latest addition to Florida’s first mobile stroke treatment unit network, which speeds care to ...

A report has warned that stroke victims are facing a postcode lottery to access lifesaving treatment. The Stroke Association ...

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

Stroke can come out of the blue, even in people who have been healthy all their lives. Unlike some other health conditions that develop gradually, a stroke occurs suddenly when blood flow to the brain ...

First Nations people in Australia's "stroke hotspot" have come together in a campaign to raise awareness of the symptoms.

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.